Brand profile · Biotechnology Research

Avance Clinical

Firle, South Australia-based Avance Clinical operates in Biotechnology Research. It is privately held, and its site is avancecro.com. It holds three addresses on record across three office countries. Headcount on record is 392. Its work is tagged oncology and infectious diseases. One Australian registration (ABN) is a confirmed match. Its latest round on record is Private equity, with no amount recorded. It is listed alongside four similar brands, mostly in Biotechnology Research.

Profile live Privately Held Founded 2019 1 entity ABN 3 office countries 1 funding round
Registry verified · ABR

Key facts

Counted staff
392
self-reported 201–500 band
Founded
2019
7 years
Legal entities
1
ABR
Office countries
3
3 addresses
Funding rounds
1
Private equity · Feb 2022
Company type
Privately Held
self-reported
Use this profile Compare Your shortlist

Legal entity

1 brand → 1 confirmed entity
  • AVANCE CLINICAL PTY LTD

    ABN47630528719

    SAHigh confidenceMatched on exact nameABR

Legal entities

Avance Clinical: 1 registry entityAvance Clinical is linked to 1 registry entity: AVANCE CLINICAL PTY LTD (ABN 47630528719, candidate).Avance ClinicalAVANCE CLINICAL PTY LTDABN 47630528719Candidate · High confidence
Show as table · Avance Clinical: 1 registry entity
Avance Clinical: 1 registry entity
AVANCE CLINICAL PTY LTDABN 47630528719
Confirmed matches0 of 1

A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.

Description

Avance Clinical is a full-service Contract Research Organization (CRO) headquartered in Australia, with extensive operations across New Zealand, Asia, North America, and Europe. As the market leaders in early phase clinical trials, we leverage the unique advantages of the Australian market, including rapid ethics approval, no IND requirement, and the 43.5% R&D tax rebate, to provide biotechs with an accelerated pathway to clinical success.

Specializing in world-class operations, we guide biotechs from early pre-clinical development through to late-phase studies. With a focus on agility, innovation, and cost-effectiveness, we deliver fast results backed by robust, globally accepted data.

With expertise spanning over 250+ indications, across all therapeutic areas, over the last three decades, Avance Clinical consistently delivers data recognized by key global regulators, including the TGA, FDA, EMA, MHRA, MFDS, and PDMA.

What sets us apart is our personalized service tailored to each client, ensuring customized, flexible solutions rather than a one-size-fits-all approach.

www.avancecro.com

Specialties

All 12 specialties
  • Renal & Cardiometabolic Disorders
  • Full service CRO
  • Preclinical & Early Phase Clinical Trials
  • Late Phase Clinical Trials
  • ClinicReady
  • GlobalReady
  • Biotech Clinical Trials
  • Rare Diseases
  • Oncology
  • Central Nervous System
  • Infectious Diseases
  • Cell & Gene Therapies

Locations

3
Countries with an office address3 addresses on record
AustraliaprimaryIndiaUnited States

Country footprint

Offices in 3 countriesCountry footprint: 3 countries, primary AU. Codes: AU, IN, US.3 countriesprimary AUAUINUS
Show as table · Offices in 3 countries
Offices in 3 countries
Countries3
Primary countryAU

All codes: AU IN US

Addresses

  • US525 S White St; Wake Forest, North Carolina 27587
  • INBengaluru, Karnataka 560102
  • AU213 Glynburn Rd; Firle, SOUTH AUSTRALIA 5070Primary

Grid intelligence Members

Funding

Last round · 18 February 2022Amount not recordedPrivate equity · investor: Riverside Company
Rounds1
Round typePrivate equity · venture round
Amount (USD)not recorded
Stage rank6
Investors named1
Since last round3 yr 11 mo

Funding

1 funding roundFunding timeline. Latest round 18 Feb 2022: Private equity, amount not disclosed.20192026Private equityamount not disclosed1 round
Show as table · 1 funding round
1 funding round
Rounds1
Axis2019 to 2026
Private equity · 18 Feb 2022not disclosed

Dated rounds only. The axis ends at the date this profile was last observed, not at today.

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Names are withheld until a consented source exists.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

Which legal entity operates under Avance Clinical?

One South Australia entity on the ABR: AVANCE CLINICAL PTY LTD (ABN 47 630 528 719), high confidence.

How many people work at Avance Clinical?

392 counted staff profiles at January 2026, inside the self-reported 201–500 band.

Where does Avance Clinical have offices?

Three addresses on record across 3 countries. Primary: 213 Glynburn Rd, Firle, SOUTH AUSTRALIA 5070.

Has Avance Clinical raised funding?

One round. Latest 18 February 2022: private equity, investor Riverside Company, no amount recorded.

What does Avance Clinical list as its specialties?

12 tags on the brand's own list, among them oncology and infectious diseases.

Which companies are listed alongside Avance Clinical?

95 profiles list Avance Clinical as a peer — 99th percentile in Biotechnology Research. It lists ten peers of its own. Southern Star Research and Emerald Clinical list it back.

What is Avance Clinical's website?